Condition
Tubal Patency
Total Trials
7
Recruiting
0
Active
0
Completed
4
Success Rate
80.0%-7% vs avg
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
Termination Rate
14.3%
1 terminated out of 7 trials
Success Rate
80.0%
-6.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
2 of 4 completed with results
Key Signals
2 with results80% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed4
Unknown2
Terminated1
Trial Success Rate
80.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT04825041CompletedPrimary
Efficacy of Hysteroscopic Bubble Test, Flow Test and Peristalsis Test.
NCT05079685UnknownPrimary
HyFoSy Versus HSG as a Diagnostic Technique for Tubal Patency.
NCT03953586CompletedPrimary
Hysteroscopic Bubble Suction Test and Tubal Peristalsis (Darwish Test) in Hydrosalpnix
NCT01880073Not ApplicableTerminatedPrimary
FemVue and Tubal Patency
NCT01725477Not ApplicableCompleted
Laparoscopic Tubal Patency Assessment
NCT02146248Not ApplicableCompletedPrimary
HSG and Tubal Patency Study
NCT02505555Unknown
Feasibility of Four-dimensional Hysterosalpingo-contrast Sonography With SonoVue for Assessment of Tubal Patency
Showing all 7 trials